The invention discloses a traditional Chinese medicine for treating deficiency of qi and yin after ovarian cancer chemotherapy. The traditional Chinese medicine is prepared from the following medicinal materials: codonopsis pilosula, astragalus membranaceus, rhizoma atractylodis macrocephalae, radix trichosanthis, schisandra chinensis, radix paeoniae alba, asparagus cochinchinensis, radix ophiopogonis, cortex moutan, radix adenophorae, poria cocos, radix rehmanniae, radix scrophulariae, colla corii asini, angelica sinensis, ligusticum wallichii, rehmannia glutinosa, fructus psoraleae, eclipta alba, fingered citron, rhizoma smilacis glabrae, radix aucklandiae, cornu cervi degelatinatum, arillus longan, solanum lyratum, dysosma versipellis, terfezia leonis, fruit of Chinese wolfberry, sulfur bacteria, spirulina, fried rice sprout, roasted malt, orange peel, cortex lycii radicis, felt covered agaric, caulis spatholobi, catharanthus roseus, cephalotaxus oliveri, fructus amomi, medicated leaven, endothelium corneum gigeriae galli, turtle shell, tortoise plastron, stir-baked squama manitis, raw oyster shell, ground beetle, pinellia ternate, caulis bambusae in taeniam, ginger and liquorice. Clinic practice proves that traditional Chinese medicine is capable of safely and effectively treating the deficiency of qi and yin after ovarian cancer chemotherapy.